Warning Letters Signal Steps to Compliance: Warning letters tell the tale of missteps by drug companies and offer a path to compliance for quality teams that monitor these enforcement actions.
| Publicado en: | BioPharm International pp. 3 - 5 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
2019 Special Issue
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141508284&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 141508284 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: 2019 Special Issue pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 141508284 141508284 ppf: 3 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Warning Letters Signal Steps to Compliance: Warning letters tell the tale of missteps by drug companies and offer a path to compliance for quality teams that monitor these enforcement actions. aug: au: PETERS, RITA sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|